Evidence map›Paper›PMID 36962556›Full record

ArticlePLOS global public health2022

Cholera epidemic amidst the COVID-19 pandemic in Moroto district, Uganda: Hurdles and opportunities for control.

Philip Orishaba, Marc Sam Opollo, Christine Nalwadda, Allan Muruta, Issa Makumbi, Kenneth Kabali, Anne Nakinsige, Phillip Lotee, Samuel I Okware, Godfrey Bwire

Open access · goldFull text read
In one paragraph

Article in PLOS global public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 1 country.

Philip OrishabaThe Centre for Rapid Evidence Synthesis, College of Health Sciences, Makerere University, Kampala, Uganda.ORCID https://orcid.org/0000-0002-1236-8529
Marc Sam OpolloDepartment of Public Health, Faculty of Health Sciences, Lira University, Lira, Uganda.ORCID https://orcid.org/0000-0003-1456-1696
Christine NalwaddaDepartment of Community Health and Behavioral Sciences, Makerere University School of Public Health, Kampala, Uganda.
Allan MurutaDepartment of Integrated Epidemiology, Surveillance and Public Health Emergencies, Ministry of Health, Kampala, Uganda.
Issa MakumbiEmergency Operation Centre (EOC), Ministry of Health, Kampala, Uganda.
Kenneth KabaliWorld Health Organization, Karamoja Regional Office, Moroto, Uganda.ORCID https://orcid.org/0000-0003-2351-3952
Anne NakinsigeDepartment of Integrated Epidemiology, Surveillance and Public Health Emergencies, Ministry of Health, Kampala, Uganda.
Phillip LoteeDepartment of Health, Moroto District Local Government, Moroto, Uganda.
Samuel I OkwareUganda National Health Research Organization (UNHRO), Entebbe, Uganda.
Godfrey BwireDepartment of Integrated Epidemiology, Surveillance and Public Health Emergencies, Ministry of Health, Kampala, Uganda.ORCID https://orcid.org/0000-0002-8376-2857
Ministry of Health · UGLira Hospital · UGMakerere University · UGMoroto Hospital · UGUganda National Health Research Organisation · UGWorld Health Organization - Uganda · UG

Funding

World Health Organization 001
6 · The paper itself

Abstract

introductionOn 21st March 2020, the first COVID-19 case was detected in Uganda and a COVID-19 pandemic declared. On the same date, a nationwide lockdown was instituted in response to the pandemic. Subsequently, more cases were detected amongst the returning international travelers as the disease continued to spread across the country. On May 14th, 2020, a cholera epidemic was confirmed in Moroto district at a time when the district had registered several COVID-19 cases and was in lockdown. This study aimed to describe the cholera epidemic and response activities during the COVID-19 pandemic as well as the hurdles and opportunities for cholera control encountered during the response. MATERIALS AND

methodsIn a cross-sectional study design, we reviewed Moroto district's weekly epidemiological records on cholera and COVID-19 from April to July 2020. We obtained additional information through a review of the outbreak investigation and control reports. Data were analyzed and presented in frequencies, proportions, attack rates, case fatality rates, graphs, and maps.

resultsAs of June 28th, 2020, 458 cases presenting with severe diarrhea and/or vomiting were line listed in Moroto district. The most affected age group was 15-30 years, 30.1% (138/458). The females, 59.0% [270/458], were the majority. The Case Fatality Rate (CFR) was 0.4% (2/458). Whereas home use of contaminated water following the vandalization of the only clean water source in Natapar Kocuc village, Moroto district, could have elicited the epidemic, implementing COVID-19 preventive and control measures presented some hurdles and opportunities for cholera control. The significant hurdles were observing the COVID-19 control measures such as social distancing, wearing of masks, and limited time in the community due to the need to observe curfew rules starting at 6.00 pm. The opportunities from COVID-19 measures complementary to cholera control measures included frequent hand washing, travel restrictions within the district & surrounding areas, and closure of markets.

conclusionCOVID-19 preventive and control measures such as social distancing, wearing of masks, and curfew rules may be a hurdle to cholera control whereas frequent hand washing, travel restrictions within the district & surrounding areas, and closure of markets may present opportunities for cholera control. Other settings experiencing concurrent cholera and COVID-19 outbreaks can borrow lessons from this study.

Identifiers

PMID36962556
PMCPMC10022206
OpenAlexW4304701161

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read20
identifiers read8
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.